Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI in Pediatric and Neonatal Patient Population (<18years)
Phase of Trial: Phase IV
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Gadoteric acid (Primary)
- Indications CNS disorders
- Focus Diagnostic use
- Sponsors Guerbet
- 13 Mar 2017 Planned End Date changed from 1 Jan 2018 to 8 Feb 2018.
- 13 Mar 2017 Planned primary completion date changed from 1 Jan 2018 to 8 Feb 2018.
- 13 Mar 2017 Status changed from not yet recruiting to recruiting.